<DOC>
	<DOCNO>NCT03087526</DOCNO>
	<brief_summary>The purprose study develop validate analytical clinical NIPD test triplet repeat disesases isolate circulate fetal trophoblastic cell ( CFTC ) analysis maternal blood , search familial mutation family risk one follow triplet repeat disease : Huntington 's disease , Myotonic dystrophy , Fragile X syndrome , spinocerebellar ataxia 1 , 2 3 .</brief_summary>
	<brief_title>NIPD CFTC Triplet Repeat Diseases</brief_title>
	<detailed_description>Non Invasive Prenatal Diagnosis ( NIPD ) , base analysis circulate cell-free fetal DNA ( cff-DNA ) promise early diagnosis monogenic disease . Such approach safer alternative invasive method prenatal testing ( amniocentesis choriocentesis ) entail significant risk miscarriage ( 0.5 % -1 % ) . However , technical issue relate characteristic cff-DNA remain allow search mutation , particular triplet expansion mutation concern rare incurable disease ( dystrophy Myotonic Steinert , Huntington 's disease , FRAXA , SCA1 , 2 , 3 ) . Indeed , strong fragmentation short size cff-DNA ( 143 bp ) allow direct detection mutation . However , Prenatal Diagnosis ( PND ) request group pathology represent second frequent PND indication national level cystic fibrosis ( ABM 2013 ) . An alternative approach perform analysis circulate fetal trophoblastic cell ( CFTC ) maternal blood . Several method use isolate CFTCs maternal blood . However , date , test reliable enough routine application replace invasive protocol . Recently , new enrichment system optimize circulate tumor cell ( CTCs ) liquid biopsy cancer . Some new technology easily apply isolation characterization CFTCs . The objective study complete NIPD service develop approach CFTC adapt analysis triplet repeat disease , perform cff-DNA . It multicenter , prospective study performance evaluation diagnostic method . The subject include pregnant woman 9 34 week gestation partner ( future father ) . Pregnant woman future father genotype ( sick healthy ) know one follow disease : Huntington 's disease , Steinert 's myotonic dystrophy , fragile X spinocerebellar ataxias 1 , 2 3 . The main objective achieve agreement gold standard ( PND amniocentesis choriocentesis ) NIPD result pregnant woman participate study ( absence presence mutate allele ) . The couple inclusion take place one participate medical genetic center genetic counsel consultation pregnancy risk one pathology mention . During visit , pregnant woman 's blood sample ( blood sample take 3 x 10 ml BCT 5 ml EDTA ) future father ( 5 ml EDTA ) carry . The duration inclusion time visit . Blood collection pregnant woman BCT tube screen CFTCs address LCCRH laboratory . The molecular analysis CFTC isolate LCCRH well genomic DNA extraction analysis ( 5 ml blood EDTA ) couple carry Laboratory Molecular Genetics ( LGM ) locate Building ( IURC - Montpellier University Hospital ) . The analysis perform simple maternal blood test allow determine whether future child affect inherited disease . With new NIPD approach , could 50 % decrease use invasive method PND . This analysis offer woman carry foetus risk triplet repeat disease . Finally , approach apply monogenic disease CFTCs isolation automation maternal blood .</detailed_description>
	<criteria>old 18 year old pregnant woman 9 34 week gestation Couple risk ( base family history echographic finding ) one follow disease : Huntington 's disease , Steinert 's myotonic dystrophy , fragile X spinocerebellar ataxias 1 , 2 3 Written inform consent obtain study Prenatal diagnosis program current pregnancy maternal blood collect Couple molecular diagnosis result one follow disease ( Huntington 's disease , Steinert 's myotonic dystrophy , fragile X spinocerebellar ataxias 1 , 2 3 ) MUST BE AVAILABLE . Couple Genomic DNA unavailable Subjects risk transmit family disease , wish know molecular status individual guardianship court order</criteria>
	<gender>Female</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Non Invasive Prenatal Diagnosis ( NIPD )</keyword>
	<keyword>Circulating Fetal Trophoblastic Cells ( CFTC )</keyword>
	<keyword>Triplet repeat disease</keyword>
	<keyword>Huntington Disease - Myotonic Dystrophy Type 1 - Spinocerebellar Ataxia 1 , 2 3</keyword>
</DOC>